Literature DB >> 20020445

Development and characterization of a human articular cartilage-derived chondrocyte cell line that retains chondrocyte phenotype.

Bryan E Hoffman1, Tonie M Newman-Tarr, Anna Gibbard, Shen Wang, Charles Hanning, Michael A Pratta, Ryan J Boyle, Sanjay Kumar, Manas K Majumdar.   

Abstract

Chondrocytes, the only cell type present in articular cartilage, regulate tissue homeostasis by a fine balance of metabolism that includes both anabolic and catabolic activities. Therefore, the biology of chondrocytes is critical for understanding cartilage metabolism. One major limitation when studying primary chondrocytes in culture is their loss of phenotype. To overcome this hurdle, limited attempts have been made to develop human chondrocyte cell lines that retain the phenotype for use as a good surrogate model. In this study, we report a novel approach to the establishment and characterization of human articular cartilage-derived chondrocyte cell lines. Adenoviral infection followed by culture of chondrocytes in 3-dimensional matrix within 48 h post-infection maintained the phenotype prior to clonal selection. Cells were then placed in culture either as monolayer, or in 3-dimensional matrix of alginate or agarose. The clones were characterized by their basal gene expression profile of chondrocyte markers. Based on type II collagen expression, 21 clones were analyzed for gene expression following treatment with IL-1 or BMP-7 and compared to similarly stimulated primary chondrocytes. This resulted in selection of two clones that retained the chondrocyte phenotype as evidenced by expression of type II collagen and other extra-cellular matrix molecules. In addition, one clone (AL-4-17) showed similar responses as primary chondrocytes when treated with IL-1 or BMP-7. In summary, this report provides a novel procedure to develop human articular cartilage-derived chondrocyte cell lines, which preserve important characteristics of articular chondrocytes and represent a useful model to study chondrocyte biology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020445     DOI: 10.1002/jcp.21994

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  Cell Tissue Res       Date:  2011-01-27       Impact factor: 5.249

2.  Immortalized Mouse Floxed Fam20c Dental Papillar Mesenchymal and Osteoblast Cell Lines Retain Their Primary Characteristics.

Authors:  Chao Liu; Xiaofang Wang; Hua Zhang; Xiaohua Xie; Peihong Liu; Ying Liu; Priyam H Jani; Yongbo Lu; Shuo Chen; Chunlin Qin
Journal:  J Cell Physiol       Date:  2015-11       Impact factor: 6.384

3.  An injectable nucleus pulposus cell-modified decellularized scaffold: biocompatible material for prevention of disc degeneration.

Authors:  Zhi Shan; Xianfeng Lin; Shengyu Wang; Xuyang Zhang; Yichuan Pang; Shengyun Li; Tianming Yu; Shunwu Fan; Fengdong Zhao
Journal:  Oncotarget       Date:  2017-06-20

4.  Impact of Fluid Flow Shear Stress on Osteoblast Differentiation and Cross-Talk with Articular Chondrocytes.

Authors:  Paige V Hinton; Katelyn J Genoud; James O Early; Fergal J O'Brien; Oran D Kennedy
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

5.  In vitro ovarian cancer model based on three-dimensional agarose hydrogel.

Authors:  Guojie Xu; Fuqiang Yin; Huayu Wu; Xuefeng Hu; Li Zheng; Jinming Zhao
Journal:  J Tissue Eng       Date:  2014-01-16       Impact factor: 7.813

6.  Articular cartilage chondrocytes express aromatase and use enzymes involved in estrogen metabolism.

Authors:  Martin Schicht; Jana Ernst; Andrea Nielitz; Lars Fester; Michael Tsokos; Saskia S Guddat; Lars Bräuer; Judith Bechmann; Karl-Stefan Delank; David Wohlrab; Friedrich Paulsen; Horst Claassen
Journal:  Arthritis Res Ther       Date:  2014-04-11       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.